๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

OP62 Polymorphisms in AKT1 and EGFR as possible new biomarkers of clinical outcome and toxicity in non-small-cell lung cancer patients treated with gefitinib

โœ Scribed by E. Giovannetti; P. Zucali; C. Tibaldi; E. Smit; A. Falcone; A. Santoro; L. Leon; G. Giaccone; R. Danesi; G. Peters


Book ID
119600875
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
41 KB
Volume
7
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES